Ocata Therapeutics Inc (OTCQB:OCAT)

Data as of 3:58pm ET
 -0.04 / -0.66%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Ocata Therapeutics, Inc. is a biotechnology company, engaged in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. It is actively conducting clinical trials for treating dry age-related macular degeneration and Stargardt's macular degeneration, in addition to several clinical and preclinical programs for other ocular therapies. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company's intellectual property portfolio includes pluripotent human embryonic stem cell, or hESC; induced pluripotent stem cell, or iPSC, platforms; and other cell therapy research programs. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA.

Contact Information

Ocata Therapeutics, Inc.
33 Locke Drive
Marlborough Massachusetts 01752
P:(508) 756-1212
Investor Relations:



Individual stakeholders1.11%
Mutual fund holders--
Other institutional--

Top Executives

Paul K. WottonPresident, Chief Executive Officer & Director
Edward H. MylesChief Operating & Financial Officer
Robert P. LanzaChief Scientific Officer
Eddy AngladeExecutive Vice President-Clinical Development
Shi-Jiang LuSenior Director-Research

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.